McDonnell Boehnen Hulbert & Berghoff LLP
Pyrimidinones as Casein Kinase II (CK2) modulators
A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.
Exelixis, Inc.
A C A
A61P C07D A61P
inventional inventional inventional
Arlyn Mohamed Abdulkader Moon Hwan Kenneth D. Jean-Claire Limun Joerg Amy Lew Elena S. Tsze H. Charles M. Csaba J. Abigail R. Peiwen Hongwang Neel Kumar Sergey Patrick Wai Ki Vicky
Arcalas Ibrahim Kim Rice Manalo Bussenius Tsuhako Koltun Tsang Blazey Peto Kennedy Zhou Du Anand Epshteyn Kearney Chan